Omalizumab ameliorates extrarespiratory symptoms in patients with aspirin-exacerbated respiratory disease.
J Allergy Clin Immunol
; 151(6): 1667-1672.e2, 2023 06.
Article
in En
| MEDLINE
| ID: mdl-36967017
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sinusitis
/
Asthma, Aspirin-Induced
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
J Allergy Clin Immunol
Year:
2023
Type:
Article
Affiliation country:
Japan